Common Contracts
5 similar Underwriting Agreement contracts by WP X Biologics LLC, China Biologic Products, Inc.
CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • June 6th, 2016 • China Biologic Products, Inc. • Biological products, (no disgnostic substances) • New York
The undersigned understands that you propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with China Biologic Products, Inc., a Delaware corporation (the “Company”), and certain selling stockholders to be named therein (the “Selling Stockholders”, providing for the public offering (the “Public Offering”) by the underwriter to be named therein (the “Underwriter”) of certain shares (the “Shares”) of the common stock of the Company, par value of $0.0001 each (the “Common Stock”).
CHINA BIOLOGIC PRODUCTS, INC. 2,775,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • June 3rd, 2016 • WP X Biologics LLC • Biological products, (no disgnostic substances) • New York
The undersigned understands that you propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with China Biologic Products, Inc., a Delaware corporation (the “Company”), and certain selling stockholders to be named therein (the “Selling Stockholders”, providing for the public offering (the “Public Offering”) by the underwriter to be named therein (the “Underwriter”) of certain shares (the “Shares”) of the common stock of the Company, par value of $0.0001 each (the “Common Stock”).
CHINA BIOLOGIC PRODUCTS, INC. 3,870,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • March 4th, 2016 • China Biologic Products, Inc. • Biological products, (no disgnostic substances) • New York
Certain stockholders (the “Selling Stockholders”) of China Biologic Products, Inc., a Delaware corporation (the “Company”) named in Schedule II hereto, the Company and the underwriter named in Schedule I hereto (the “Underwriter”) entered into an underwriting agreement dated March 1, 2016 (the “Prior Agreement”) in connection with sales of 3,500,000 shares of common stock of the Company, par value $0.0001 per share. The Company, the Selling Stockholders and the Underwriter hereby agree that the Prior Agreement shall be amended and restated in its entirety by this Agreement and further agree as follows.
CHINA BIOLOGIC PRODUCTS, INC. 3,870,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • March 3rd, 2016 • WP X Biologics LLC • Biological products, (no disgnostic substances) • New York
The undersigned understands that you propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with China Biologic Products, Inc., a Delaware corporation (the “Company”), and certain selling stockholders to be named therein (the “Selling Stockholders”, providing for the public offering (the “Public Offering”) by the underwriter to be named therein (the “Underwriter”) of certain shares (the “Shares”) of the common stock of the Company, par value of $0.0001 each (the “Common Stock”).
CHINA BIOLOGIC PRODUCTS, INC. 3,500,000 SHARES OF COMMON STOCK (PAR VALUE $0.0001 PER SHARE) UNDERWRITING AGREEMENTUnderwriting Agreement • March 3rd, 2016 • WP X Biologics LLC • Biological products, (no disgnostic substances) • New York
The undersigned understands that you propose to enter into an Underwriting Agreement (the “Underwriting Agreement”) with China Biologic Products, Inc., a Delaware corporation (the “Company”), and certain selling stockholders to be named therein (the “Selling Stockholders”, providing for the public offering (the “Public Offering”) by the underwriter to be named therein (the “Underwriter”) of certain shares (the “Shares”) of the common stock of the Company, par value of $0.0001 each (the “Common Stock”).
